KeyGene, Floragenex Settle Patent Dispute, Enter Licensing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – KeyGene and Floragenex today said that they have agreed to end a legal dispute and have entered into a licensing agreement covering sequence-based genotyping technology.

KeyGene had filed the patent infringement suit against Floragenex last year in the US District Court for the District of Orgeon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.